Abstract
P-231 Interim results of a phase II study of fluorouracil (FU), leucovorin (LV), and nanoliposomal irinotecan (nal-IRI) in previously treated advanced biliary tract cancer (NAPOLI-2)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have